[ad_1]
The goal is to make the vaccine available in Europe by the end of the year.
The European Medicines Agency (EMA) has announced that it will convene an extraordinary meeting no later than December 29 to decide on the conditional approval of the COVID-19 vaccine, developed by the German company BioNTech in partnership with the American company Pfizer. The information was provided by the AFP news agency.
#SpajaNasZodpovednost
Aktuality.sk shows the true face of Slovakia, without obscuring the facts and bending reality. We bring you reliable and balanced news every day. Your support will ensure that our content remains open to those who cannot afford it.
Do you already have an account? sign in
[ad_2]
Source link
